20 July 2009
Dr Aloka Srinivasan of the FDA's Office of Generic Drugs speaks about question-based reviews for generic drugs.
 |
17 July 2009
The European Pharmacopoeia Commission, which will celebrate its 60th anniversary this year, has announced progress towards international harmonization, as well as other ongoing activities, at the 134th session of the European Pharmacopoeia in France.
|
17 July 2009
Resistance to the social networking revolution has been particularly high amongst pharmaceutical industry professionals, though now it seems that more and more are coming round to the idea. Interestingly, it?s not only the pharma elite that are jumping on the bandwagon; so too are government agencies and, most notably, the FDA.
|
17 July 2009
Less well-known tropical diseases are receiving growing attention and research efforts from the pharmaceutical industry, according to a report from the Federation of Pharmaceutical Manufacturers & Associations (IFPMA).
|
17 July 2009
Last week, the US House of Representatives passed H.R. 2997, the Fiscal Year 2010 Agriculture-FDA Appropriations bill, which sets aside $2.995 billion for the US Food and Drug Administration.
|
17 July 2009
The Society of Chemical Manufacturers and Affiliates (SOCMA) this week stated its support to the US Senate for approving legislation that would extend existing chemical security standards for one more year.
|
17 July 2009
The UK's largest counterfeit drug operation has ended in the sentencing of its seventh and final member.
|
17 July 2009
In the wake of Dow Chemical's announcement that it is to close facilities in the UK, the country's biggest union, Unite, has called for urgent intervention from the Government to avert, what it believes, could be a crisis in the UK chemical sector.
|
17 July 2009
The FDA issued a draft guidance for industry, Incorporation of Physical-Chemical Identifiers into Solid Oral Dosage Form Drug Products for Anticounterfeiting, on July 13.
|
| 
